Nael M. Mostafa

Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa

Alexa B. Kimball, Martin M. Okun, David Williams et al. · New England Journal of Medicine · 2016 · 777 citations

Medicine, Dermatology, Pharmacology +16

Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis

Yasuo Suzuki, Satoshi Motoya, Hiroyuki Hanai et al. · Journal of Gastroenterology · 2013 · 164 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Veliparib in combination with whole brain radiation therapy in patients with brain metastases: results of a phase 1 study

Minesh P. Mehta, Ding Wang, Fen Wang et al. · Journal of Neuro-Oncology · 2015 · 103 citations

Medicine, Oncology, Radiation Oncology +14

Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind study

R. Landewé, Joachim Sieper, Philip J. Mease et al. · The Lancet · 2018 · 99 citations

Medicine, Pharmacotherapy, Rheumatology +11

Randomized phase II study evaluating veliparib (ABT-888) with temozolomide in patients with metastatic melanoma

Mark R. Middleton, Philip Friedlander, Omid Hamid et al. · Annals of Oncology · 2015 · 92 citations · Full text

Medicine, Oncology, Pharmacology +13